Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø

XClose

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Therapeutic Innovation Networks

Home
Menu

Clinical Evaluation (Devices)

Medical device manufacturers must conduct clinical evaluation to compare a new device to standard of care practice. This section includes considerations needed here for market approval and adoption.

Devices roadmap

people talking
STUDY DESIGN/PATIENT & PUBLIC INVOLVEMENT (PPI)

Medical device manufacturers are required to conduct clinical evaluation (incl. literature review, trials) to compare a new device to standard of care practice, or established similar devices, for (pre-)market approval and adoption

  • Undertake risk-benefit assessment of the new device under actual clinical conditions of use
  • ISO 14155 Clinical Investigation of Medical Devices for Human Subjects - Good clinical practice. An international standard for studies carried out in human subjects to assess the safety and performance of medical devices for regulatory purposes

There’s also a great guidance document from the International Medical Device Regulators Forum (IMDRF) that would be useful to include:

Important PPI considerations:

  • Understanding the patient and clinician needs – Does your TPP meet all of the essential requirements expressed by frontline clinical care providers, patient and public contributors (PPI)?
  • Research is carried out ‘with’ or ‘by’ members of the public or potential patients etc. – Advisory members of a project steering group

Further information on PPI can be found via INVOLVE:Ìý

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Support:Ìý

The Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Translational Research Office (TRO) can help with the timely identification of future needs or opportunities for diversifying, as well as advising on appropriateÌýpatient groups and charities to consider.Ìý

Contact the Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Translational Research Office

documents
DOCUMENTATION:

Although resource-intensive from the start, the development of a comprehensive Device master file unquestionably increases commercial attractiveness and value of a product to a potential buyer, since it avoids the need to ‘back-fill’ the history and results of the Device design, manufacture & testing.Ìý

money hands
¹ó±õ±·´¡±·°ä·¡:Ìý

Regardless of altruistic drivers, clinical evaluation of devices has significant costs that must be met.

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Support:

The Translational Research Office (TRO)Ìýsupports Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø device developers in attracting and managing public, commercial, investor and philanthropic funding for clinical studies of devices, appropriately costed in partnership with the JRO.Ìý

Contact the TRO

magnifying glass
REGULATORY APPROVALS:Ìý

Medical device developers requireÌýlocal, national & international approvals for device evaluations in hospital(s)Ìýand must engage with regulators in advance to identify and address potential hurdles to authorisations.Ìý

Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø Support:Ìý

The Joint Research Office (JRO) and Translational Research Office (TRO) support device developers in the above points, as well as ensuring rigorous compliance of Ïã¸ÛÁùºÏ²ÊÖÐÌØÍø researchers and contractors with international standards.Ìý